Nashville, TN 的 心臟衰竭 臨床試驗
19 項針對 心臟衰竭 的研究正在 Nashville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
招募中
- St.Thomas Health, Nashville
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
招募中2 期
- Vanderbilt University Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
招募中
- Saint Thomas Research Institute, Nashville
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
招募中3 期
- Research Site, Nashville
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
招募中3 期
- Vanderbilt University Medical Center, Nashville
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
招募中3 期
- Research Site, Nashville
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
招募中3 期
- Nashville, TN Investigative Site 10071, Nashville
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
招募中觀察性研究
- Vanderbilt University, Nashville
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
招募中1 期
- Vanderbilt University Medical Center, Nashville
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
招募中觀察性研究
- Nashville, Nashville
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
招募中觀察性研究
- Tristar Centennial Medical Ctr, Nashville
- Saint Thomas Health, Nashville
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
招募中3 期
- Tenax Investigational Site, Nashville
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
招募中觀察性研究
- Vanderbilt University, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
招募中
- Vanderbilt, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
招募中觀察性研究歡迎健康志工
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
招募中
- Centennial Medical Center, Nashville
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
招募中
- Vanderbilt University Medical Center, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
招募中觀察性研究
- Vanderbilt University Medical Center, Nashville
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
招募中觀察性研究
- Vanderbilt University Medical Center, Nashville
其他城市的 心臟衰竭 試驗
- New York City, NY51 項研究
- Boston, MA44 項研究
- Dallas, TX42 項研究
- Houston, TX36 項研究
- Cleveland, OH33 項研究
- Chicago, IL31 項研究
- Philadelphia, PA31 項研究
- San Francisco, CA29 項研究
- Durham, NC26 項研究
- St. Louis, MO26 項研究
- Atlanta, GA25 項研究
- Kansas City, MO25 項研究
Nashville 的其他研究
- 非小細胞肺癌97 項研究
- 乳癌81 項研究
- 轉移性癌症70 項研究
- 大腸直腸癌69 項研究
- 癌症（所有類型）65 項研究
- 卵巢癌49 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 頭頸部鱗狀細胞癌39 項研究
- 胰臟癌39 項研究
- 子宮內膜癌38 項研究
- 黑色素瘤33 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。